Breaking News Instant updates and real-time market news.

AXON

Axovant Sciences

$2.27

-0.16 (-6.58%)

05:58
01/12/18
01/12
05:58
01/12/18
05:58

Axovant Sciences downgraded to Market Perform from Outperform at Cowen

AXON Axovant Sciences
$2.27

-0.16 (-6.58%)

12/21/17
JEFF
12/21/17
DOWNGRADE
Target $6
JEFF
Hold
Axovant Sciences downgraded to Hold from Buy at Jefferies
Jefferies analyst Michael Yee downgraded Axovant Sciences to Hold and cut his price target for the shares to $6 from $12. The company needs "more interesting" in-licensed compounds to renew investor interest in 2018 and to demonstrate the new CEO can drive shareholder value, Yee tells investors in a research note. The analyst views the stock's risk/reward as balanced at current levels.
12/21/17
12/21/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PG&E (PCG) downgraded to Sector Perform from Outperform at RBC Capital with analyst Shelby Tucker stating that the company's "unexpected" decision to suspend its dividend suggests greater risk than he had assumed regarding the regulatory treatment of the California wildfires in October. 2. ConocoPhillips (COP) downgraded to Outperform from Focus List at Scotia Howard Weil. 3. Axovant Sciences (AXON) downgraded to Hold from Buy at Jefferies with analyst Michael Yee saying the company needs "more interesting" in-licensed compounds to renew investor interest in 2018 and to demonstrate the new CEO can drive shareholder value. 4. Lazard (LAZ) downgraded to Neutral from Buy at Buckingham with analyst James Mitchell saying he sees little operating leverage from the tax rate cut and said weakening restructuring revenues will be a drag on growth. 5. SunTrust (STI) downgraded to Neutral from Outperform at Wedbush with analyst Peter Winter citing valuation with the shares up 19% year-to-date. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/18
JMPS
01/09/18
NO CHANGE
Target $11
JMPS
Outperform
JMP says Axovant data still support nelotanserin advancement
JMP Securities analyst Jason Butler acknowledges that the nelotanserin Phase 2 results reported by Axovant Sciences were not the best-case outcome, but he remains encouraged by the efficacy signals seen in this small, short-term trial and still thinks the results support clinical advancement. He maintains a 65% probability of approval for nelotanserin, but pushed out his launch expectation to 2022 from 2020. Butler cut his price target on Axovant to $11 from $19 but keeps an Outperform rating on the shares, which fell 57% yesterday to $2.31.
01/10/18
CHDN
01/10/18
UPGRADE
CHDN
Neutral
Axovant Sciences upgraded to Neutral from Sell at Chardan
Chardan analyst Gbola Amusa upgraded Axovant Sciences to Neutral from Sell citing share underperformance and lowered its price target to $2 from $2.50.

TODAY'S FREE FLY STORIES

08:02
05/24/18
05/24
08:02
05/24/18
08:02
Conference/Events
Morgan Stanley to hold a symposium »

2nd Annual Small &…

MYO

Myomo

$3.28

-0.02 (-0.61%)

08:02
05/24/18
05/24
08:02
05/24/18
08:02
Hot Stocks
Myomo announces MyoPro availability in 16 new U.S. locations »

Myomo announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKY

Skyline

$29.22

-0.56 (-1.88%)

08:01
05/24/18
05/24
08:01
05/24/18
08:01
Initiation
Skyline initiated  »

Skyline initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$31.79

-0.08 (-0.25%)

08:01
05/24/18
05/24
08:01
05/24/18
08:01
Conference/Events
Detroit Economic Club to hold a luncheon »

Tony James, Executive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

WHR

Whirlpool

$164.63

0.3 (0.18%)

08:01
05/24/18
05/24
08:01
05/24/18
08:01
Hot Stocks
Whirlpool announces preliminary results of modified Dutch auction tender offer »

Whirlpool Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

HFC

HollyFrontier

$73.67

0.75 (1.03%)

08:00
05/24/18
05/24
08:00
05/24/18
08:00
Recommendations
HollyFrontier analyst commentary  »

HollyFrontier price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$36.72

0.35 (0.96%)

08:00
05/24/18
05/24
08:00
05/24/18
08:00
Options
JD.com call buyer realizes 1% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNP

Union Pacific

$144.26

1.36 (0.95%)

07:59
05/24/18
05/24
07:59
05/24/18
07:59
Initiation
Union Pacific initiated  »

Union Pacific resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

NCR

NCR Corp.

$30.75

-0.4 (-1.28%)

07:58
05/24/18
05/24
07:58
05/24/18
07:58
Recommendations
NCR Corp. analyst commentary  »

NCR Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:55
05/24/18
05/24
07:55
05/24/18
07:55
Conference/Events
Federal Reserve Bank of Philadelphia President speaks at a conference »

Philadelphia Federal…

MCRB

Seres Therapeutics

$8.12

0.16 (2.01%)

07:55
05/24/18
05/24
07:55
05/24/18
07:55
Conference/Events
Seres Therapeutics to hold a research and development day »

Microbiome Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 02

    Jun

OKTA

Okta

$49.49

0.99 (2.04%)

07:52
05/24/18
05/24
07:52
05/24/18
07:52
Recommendations
Okta analyst commentary  »

Okta price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 06

    Jun

  • 12

    Jun

INTU

Intuit

$196.15

5.74 (3.01%)

07:51
05/24/18
05/24
07:51
05/24/18
07:51
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

CIT

CIT Group

$55.27

-0.06 (-0.11%)

07:51
05/24/18
05/24
07:51
05/24/18
07:51
Hot Stocks
CIT Group announces preliminary results of cash tender offer for common stock »

CIT Group announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDU

New Oriental Education

$101.38

4.82 (4.99%)

07:50
05/24/18
05/24
07:50
05/24/18
07:50
Downgrade
New Oriental Education rating change  »

New Oriental Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

TAL

TAL Education

$43.74

1.11 (2.60%)

07:50
05/24/18
05/24
07:50
05/24/18
07:50
Upgrade
TAL Education rating change  »

TAL Education upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:48
05/24/18
05/24
07:48
05/24/18
07:48
Conference/Events
Federal Reserve Bank of Atlanta president delivers opening remarks at conference »

Atlanta Federal Reserve…

DRI

Darden

$85.72

-0.23 (-0.27%)

07:47
05/24/18
05/24
07:47
05/24/18
07:47
Recommendations
Darden analyst commentary  »

Darden added to Top Picks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

PBR

Petrobras

$15.10

-0.6 (-3.82%)

07:46
05/24/18
05/24
07:46
05/24/18
07:46
Downgrade
Petrobras rating change  »

Petrobras downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.10

-0.6 (-3.82%)

07:46
05/24/18
05/24
07:46
05/24/18
07:46
Technical Analysis
Technical Take: Petrobras falls on diesel price cuts, regulator scrutiny »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRPO

Precipio

$0.50

0.0143 (2.94%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Hot Stocks
Precipio receives first order for liquid biopsy DNA enrichment sales in Europe »

Precipio entered into an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$32.87

0.56 (1.73%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Initiation
uniQure initiated  »

uniQure initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$98.72

1.16 (1.19%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Recommendations
Microsoft analyst commentary  »

Microsoft stock should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

07:39
05/24/18
05/24
07:39
05/24/18
07:39
Technical Analysis
Technical Take: Williams-Sonoma nears 52-week high after earnings beat »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$34.05

0.06 (0.18%)

07:38
05/24/18
05/24
07:38
05/24/18
07:38
Recommendations
L Brands analyst commentary  »

L Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.